Literature DB >> 7735836

The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation.

J W Schwabe1, L Chapman, D Rhodes.   

Abstract

BACKGROUND: Structural studies of protein-DNA complexes have tended to give the impression that DNA recognition requires a unique molecular interface. However, many proteins recognize DNA targets that differ from what is thought to be their ideal target sequence. The steroid hormone receptors illustrate this problem in recognition rather well, since consensus DNA targets are rare.
RESULTS: Here we describe the structure, at 2.6 A resolution, of a complex between a dimer of the DNA-binding domain from the human oestrogen receptor (ERDBD) and a non-consensus DNA target site in which there is a single base substitution in one half of the palindromic binding site. This substitution results in a 10-fold increase in the dissociation constant of the ERDBD-DNA complex. Comparison of this structure with a structure containing a consensus DNA-binding site determined previously, shows that recognition of the non-consensus sequence is achieved by the rearrangement of a lysine side chain so as to make an alternative base contact.
CONCLUSIONS: This study suggests that proteins adapt to recognize different DNA sequences by rearranging side chains at the protein-DNA interface so as to form alternative patterns of intermolecular contacts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735836     DOI: 10.1016/s0969-2126(01)00150-2

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  25 in total

1.  Plasticity in protein-DNA recognition: lac repressor interacts with its natural operator 01 through alternative conformations of its DNA-binding domain.

Authors:  Charalampos G Kalodimos; Alexandre M J J Bonvin; Roberto K Salinas; Rainer Wechselberger; Rolf Boelens; Robert Kaptein
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

Review 2.  The different (sur)faces of Rap1p.

Authors:  B Piña; J Fernández-Larrea; N García-Reyero; F-Z Idrissi
Journal:  Mol Genet Genomics       Date:  2003-01-25       Impact factor: 3.291

3.  DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.

Authors:  Annemie Haelens; Guy Verrijdt; Leen Callewaert; Valerie Christiaens; Kris Schauwaers; Ben Peeters; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

4.  Does TATA matter? A structural exploration of the selectivity determinants in its complexes with TATA box-binding protein.

Authors:  N Pastor; L Pardo; H Weinstein
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

5.  Plasticity in Repressor-DNA Interactions Neutralizes Loss of Symmetry in Bipartite Operators.

Authors:  Deepti Jain; Naveen Narayanan; Deepak T Nair
Journal:  J Biol Chem       Date:  2015-10-28       Impact factor: 5.157

6.  Sequence-specific DNA-binding dominated by dehydration.

Authors:  T Lundbäck; T Härd
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 7.  Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.

Authors:  Vincent J Hilser; E Brad Thompson
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

8.  Binding of the estrogen receptor to DNA. The role of waters.

Authors:  D Kosztin; T C Bishop; K Schulten
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

9.  How hormone receptor-DNA binding affects nucleosomal DNA: the role of symmetry.

Authors:  T C Bishop; D Kosztin; K Schulten
Journal:  Biophys J       Date:  1997-05       Impact factor: 4.033

10.  DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia.

Authors:  H Hauksdóttir; M L Privalsky
Journal:  Cell Growth Differ       Date:  2001-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.